
Gherman Novakovsky
Articles
-
Feb 16, 2023 |
cell.com | Gherman Novakovsky |Shugo Sasaki |Oriol Fornes |Meltem E. Omur
IntroductionOver 400 million people worldwide live with diabetes, a chronic disease caused by insulin deficiency or resistance. A promising emerging treatment approach uses human embryonic stem cell (hESC)-derived insulin-producing cells to replace lost or dysfunctional patient cells.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →